和铂医药-B盘中涨逾8% 与阿斯利康达成重大战略合作

新浪网
25 Mar

和铂医药-B早盘一度涨逾8%,截至发稿,股价上涨3.87%,现报8.58港元,成交额4814.45万港元。和铂医药近期宣布,与阿斯利康达成重大战略合作,阿斯利康将以每股1.38美元(约10.74港元)认购和铂医药9.15%股份,总金额约1.05亿美元。认购价较签约前收市价溢价37.2%,所得资金将用于研发、营运及一般营运资金需求。双方同时签署了全球战略合作协议,共同研发针对免疫性疾病、肿瘤等多种...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10